Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells

Angiogenesis

Volumn 16, Issue 2, 2013, Pages 309-327

  Cattaruzza, Sabrina ^a   Ozerdem, Ugur ^b   Denzel, Martin ^c   Ranscht, Barbara ^c   Bulian, Pietro ^a   Cavallaro, Ugo ^d   Zanocco, Daniela ^a   Colombatti, Alfonso ^a   Stallcup, William B ^c   Perris, Roberto ^a,e  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^c BURNHAM INSTITUTE   (United States)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

Author keywords

Angiogenesis; FGF signalling; NG2 CSPG4; Pericytes; Proteoglycan

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; NG2 PROTEIN; PROTEOGLYCAN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; WILD TYPE;

ANIMALS; ANTIGENS; CORNEA; FIBROBLAST GROWTH FACTORS; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, KNOCKOUT; MITOGENS; PERICYTES; PROTEOGLYCANS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS;

EID: 84877945230     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9316-7     Document Type: Article

References (57)

1. Chen C-W, Montelatici E, Crisan M, Corselli M, Huard J, Lazzari L, Péault B (2009) Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both ? Cytokine Growth Factor Rev 20:429-434
2. Ozerdem U, Stallcup WB (2003) Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 6:241-249 (Pubitemid 38506669)
3. Virgintino D, Girolamo F, Erede M, Capobianco C, Robertson D, Stallcup WB, Perris R, Roncali L (2007) An intimate interplay between migrating pericytes and endothelial cells governs human foetal brain angiogenesis. Angiogenesis 10:35-45 (Pubitemid 46356222)
4. Virgintino D, Ozerdem U, Girolamo F, Roncali L, Stallcup WB, Perris R (2007) Reversal of the cellular roles in angiogenesis: implications for anti-angiogenic therapy. J Vasc Res 45:129-131
5. Tigges U, Hyer EG, Scharf J, Stallcup WB (2008) FGF2-dependent neovascularization of subcutaneous matrigel plugs is initiated by bone marrow-derived pericytes and macrophages. Development 135:523-532
6. Ozerdem U, Stallcup WB (2004) Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis 7:307-311 (Pubitemid 40767932)
7. Ozerdem U (2006) Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer. Prostate 66:294-304 (Pubitemid 43191229)
8. + perivascular progenitor cells in tumors regulate pericyte differentiation and vascular survival. Nat Cell Biol 7:870-879 (Pubitemid 41486287)
9. Huang FJ, You WK, Bonaldo P, Seyfried TN, Pasquale EB, Stallcup WB (2010) Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. Dev Biol 344:1035-1046
10. Grako KA, Stallcup WB (1995) Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp Cell Res 221:231-240
11. Lindahl P, Johansson B, Leveen P, Betzholtz C (1997) Pericyte loss and microaneurysm formation in PDGF-B deficient mice. Science 277:242-245 (Pubitemid 27446080)
12. Grako KA, Ochiya T, Barritt D, Nishiyama A, Stallcup WB (1999) PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. J Cell Sci 112:905-915 (Pubitemid 29179323)
13. Hirschi K, Rohovski S, Beck L, Smith S, D'Amore P (1999) Endothelial cells modulate the proliferation of mural cell precursors via PDGF-BB and heterotypic cell contact. Circ Res 84:298-305 (Pubitemid 29095570)
14. Sennino B, Falcòn BL, McCauley D, Le T, McCauley T, Kurz JC, Haskell A, Epstein DM, McDonald DM (2007) Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102. Cancer Res 67:7358-7367 (Pubitemid 47206566)
15. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C (2010) Pericytes regulate the blood-brain barrier. Nature 468:557-561
16. Goretzki L, Burg M, Grako KA, Stallcup WB (1999) High-affinity of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J Biol Chem 274:16831-16837 (Pubitemid 29275133)
17. Suyama K, Shapiro I, Guttman M, Hazon RB (2002) A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2:301-314 (Pubitemid 41043964)
18. Böttcher RT, Pollet N, Delius H, Niehrs C (2004) The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling. Nat Cell Biol 6:38-44 (Pubitemid 38425728)
19. Gotoh N, Manova K, Tanaka S, Murohashi M, Hadari Y, Lee A, Hamada Y, Hiroe T, Ito M, Kurihara T, Nakazato H, Shibuya M, Lax I, Lacy E, Schlessinger J (2005) The docking protein FRS2α is an essential component of multiple fibroblast growth factor responses during early mouse development. Mol Cell Biol 25:4105-4116 (Pubitemid 40617657)
20. Sanchez-Heras E, Howell FV, Williams GP, Doherty PT (2006) The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural adhesion molecule. J Biol Chem 281:35208-35216 (Pubitemid 46036559)
21. Francavilla C, Cattaneo P, Berezin V, Bock E, Ami D, De Marco A, Christofori G, Cavallaro U (2009) The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J Cell Biol 187:1101-1116
22. Cavallaro U, Dejana E (2011) Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol 12:189-197
23. Allen BL, Filla MS, Rapraeger AC (2001) Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol 155:845-857 (Pubitemid 34286236)
24. Loo B-M, Kreuger J, Jalkanen M, Lindahl U, Salmivirta M (2001) Binding of heparin/heparan sulfate to fibroblast growth factor. J Biol Chem 276:18668-18876
25. Zhang Z, Coomans C, David G (2001) Membrane heparan sulfate proteoglycan-supported FGF-2-FGFR1 signaling. J Biol Chem 276:41921-41929 (Pubitemid 37371091)
26. Wu ZL, Zhang L, Yabe T, Kuberan B, Beeler DL, Love A, Rosenberg RD (2003) The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J Biol Chem 278:17121-17129 (Pubitemid 36799590)
27. Ibrahimi OA, Zhang F, Lang Hrstka SC, Mohammadi M, Linhardt RJ (2004) Kinetic model for FGF, FGFR and proteoglycan signal transduction complex assembly. Biochemistry 43:4724-4730 (Pubitemid 38509093)
28. Chu CL, Buczek-Thomas JA, Nugent MA (2004) Heparan sulfate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism. Biochem J 379:331-341 (Pubitemid 38570106)
29. Chu CL, Goerges AL, Nugent MA (2005) Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. Biochemistry 44:12203-12213 (Pubitemid 41285719)
30. Gopalakrishnan M, Forsten-Williams K, Nugent MA, Tauber UC (2005) Effects of receptor clustering on ligand dissociation kinetics: theory and simulations. Biophys J 89:3686-3700 (Pubitemid 41725594)
31. Forsten-Williams K, Chua CC, Nugent MA (2005) The kinetics of FGF-2 binding to heparin sulfate proteoglycans and MAP kinase signaling. J Theor Biol 233:483-489 (Pubitemid 40320595)
32. Patel VN, Likar KM, Zisman-Rozen S, Cowherd SN, Lassiter KS, Sher I, Yates EA, Turnbull JE, Ron D, Hoffman MP (2008) Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation. J Biol Chem 283:9308-9317
33. Maccarana M, Casu B, Lindahl U (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 268:23898-23905 (Pubitemid 23335364)
34. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC (1993) Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2 and FGF-4. J Biol Chem 268:23906-23914 (Pubitemid 23335365)
35. Kreuger J, Salmivirta M, Sturiale L, Giménez-Gallego G, Lindahl U (2001) Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem 276:30744-30752
36. Delehedde M, Lyon M, Gallagher JT, Rudland PS, Fernig DG (2002) Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. Biochem J 366:235-244 (Pubitemid 34971823)
37. Ostrovsky O, Berman B, Gallagher J, Mulloy B, Fernig DG, Delehedde M, Ron D (2002) Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem 277:2444-2453 (Pubitemid 34953266)
38. Powell AK, Fernig DG, Turnbull JE (2002) Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex. J Biol Chem 277:28554-28563 (Pubitemid 41079282)
39. Luo Y, Ye S, Kan M, McKeehan KW (2006) Structural specificity in a FGF7-affinity purified heparin octasaccharide required formation of a complex with FGF7 and FGFRIIIb. J Cell Biochem 97:1241-1256
40. Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL (2000) Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407:1029-1034
41. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6:743-750
42. Robinson CJ, Harmer NJ, Goodger SJ, Blundell TL, Gallagher JT (2005) Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes. J Biol Chem 280:42274-42282 (Pubitemid 43023198)
43. Harmer NJ, Robinson CJ, Adam LE, Ilag LL, Robinson CV, Gallagher JT, Blundell TL (2006) Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin. Biochem J 393:741-748 (Pubitemid 43163814)
44. Stringer SE (2006) The role of heparan sulphate proteoglycans in angiogenesis. Biochem Soc Trans 34:351-353 (Pubitemid 43953984)
45. Fuster MM, Wang L, Castagnola J, Sikara L, Reddi K, Lee PHA, Radek KA, Schuksz M, Bishop JR, Gallo RL, Sriramarao P, Esko JD (2007) Genetic alteration of endothelial heparan sulphate selectively inhibits tumor angiogenesis. J Cell Biol 177:1-11 (Pubitemid 46718281)
46. Ozerdem U, Grako K, Dahlin-Huppe K, Monosov E, Stallcup WB (2001) The NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 222:218-227 (Pubitemid 32937594)
47. Pluschke G, Vanek M, Evans A, Dittmar T, Schmid P, Itin P, Filardo EJ, Reisfeld RA (1996) Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc Natl Acad Sci USA 93:9710-9715 (Pubitemid 26296674)
48. Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM (2006) Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 281:15694-15700 (Pubitemid 43848456)
49. Kenyon BM, Browne F, D'Amato RJ (1997) Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 64:971-978 (Pubitemid 27314772)
50. Stallcup WB, Dahlin-Huppe K (2001) Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization. J Cell Sci 114:2315-2325 (Pubitemid 32633702)
51. Rahmoune H, Chen H-L, Gallagher JT, Rudland PS, Fernig DG (1998) Interaction of heparin sulfate from mammary cells with acidic fibroblast growth factor (FGF and basic FGF). Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate. J Biol Chem 273:7303-7310 (Pubitemid 28152748)
52. Ozerdem U, Monosov E, Stallcup WB (2002) NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvasc Res 63:129-134 (Pubitemid 34971515)
53. Turner N, Grose R (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10:110-129
54. Guimond SE, Rudd TR, Skidmore MA, Ori A, Gaudesi D, Cosentino C, Guerrini M, Edge R, Collison D, McInnes E, Torri G, Turnbull JE, Fernig DG, Yates EA (2009) Cations modulate polysaccharide structure to determine FGF-FGFR signaling: a comparison of signaling and inhibitory polysaccharide interactions with FGF-1 in solution. Biochemistry 48:4772-4779
55. Zhu H, Duchesne L, Rudland PS, Fernig DG (2010) The heparan sulfate co-receptor and the concentration of fibroblast growth factor-2 independently elicit different signalling patterns from the fibroblast growth factor receptor. Cell Commun Signal 8:14
56. Makagiansar IT, Williams S, Dahlin-Huppe K, Fukushi J, Mustelin T, Stallcup WB (2004) Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility. J Biol Chem 279:52262-52270 (Pubitemid 40066523)
57. Makagiansar IT, Williams S, Mustelin T, Stallcup WB (2007) Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration. J Cell Biol 178:155-165 (Pubitemid 47026410)